NDC 31722-627 – Lacosamide
Lacosamide 10 mg/mL · Solution · Oral
Product NDC31722-627
Product details
- Brand name
- Lacosamide
- Generic name
- Lacosamide
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA209301
- Marketed since
- May 31, 2022
- Listing expires
- December 31, 2026
Active ingredients
- Lacosamide 10 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 31722-627-26 | 1 BOTTLE in 1 CARTON (31722-627-26) / 200 mL in 1 BOTTLE | May 31, 2022 |
| 31722-627-46 | 1 BOTTLE in 1 CARTON (31722-627-46) / 465 mL in 1 BOTTLE | May 31, 2022 |
Recalls mentioning this NDC
- D-0094-2023 Dec 21, 2022 · Class III
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Other Lacosamide products
- 60687-847 Lacosamide 10 mg/mL · Solution · American Health Packaging
- 70954-488 Lacosamide 10 mg/mL · Solution · ANI Pharmaceuticals, Inc.
- 59651-016 Lacosamide 10 mg/mL · Solution · Aurobindo Pharma Limited
- 72162-2637 Lacosamide 10 mg/mL · Solution · Bryant Ranch Prepack
- 68462-940 Lacosamide 10 mg/mL · Solution · Glenmark Pharmaceuticals Limited
- 85742-014 Lacosamide 10 mg/mL · Solution · Kanchan Healthcare Inc
- 69315-318 Lacosamide 10 mg/mL · Solution · Leading Pharma, LLC
- 0904-7463 Lacosamide 50 mg/5mL · Solution · Major Pharmaceuticals
- 0904-7464 Lacosamide 100 mg/10mL · Solution · Major Pharmaceuticals
- 72603-305 Lacosamide 10 mg/mL · Solution · NorthStar Rx LLC
- 72205-034 Lacosamide 10 mg/mL · Solution · Novadoz Pharmaceuticals LLC
- 0121-2024 Lacosamide 100 mg/10mL · Solution · PAI Holdings, LLC dba PAI Pharma